论文部分内容阅读
目的为了研究联合应用血液透析和血液灌注方法在治疗尿毒症患者高血压方面的作用。方法将2013年5月到2015年6月来我院进行血液透析治疗的82例尿毒症患者,按照统计学的分类方分为对照组和观察组。对照组(常规血液透析的方法进行治疗)41例,观察组(常规进行血液透析方法的同时,每周增加一次血液灌注)41例。连续治疗4个月后,对两组患者的血压、血钾及血钠的浓度进行比较。结果加用血液灌注方法的患者在治疗后,血压降低明显、血钾血钠的浓度低于单纯应用血液透析的患者。结论血液透析与血液灌注联合应用的方法,在治疗尿毒症患者难治性高血压方面,具有明显的而优势,值得在临床推广应用。
Objective To investigate the role of combined hemodialysis and hemoperfusion methods in the treatment of hypertension in uremic patients. Methods From May 2013 to June 2015, 82 patients with uremia treated by hemodialysis in our hospital were divided into control group and observation group according to the classification of statistics. Control group (routine hemodialysis method for treatment) 41 cases, the observation group (conventional hemodialysis method, while increasing blood perfusion) in 41 cases. After 4 months of continuous treatment, blood pressure, serum potassium and serum sodium concentrations were compared between the two groups. Results Patients treated with hemoperfusion had a significant reduction in blood pressure after treatment, with concentrations of serum potassium and sodium being lower than those receiving hemodialysis alone. Conclusion Hemodialysis and blood perfusion combined with the method of treatment of uremic patients with refractory hypertension, has obvious advantages, it is worth in the clinical application.